SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants
Authors:
- John KubaleJohn Kubale
- PARIS Study TeamPTPARIS Study Team
- Aubree GordonAubree Gordon
- Florian KrammerFlorian Krammer
- Viviana SimonViviana Simon
- Hala AlshammaryHAHala Alshammary
- Angela A. AmoakoAAAngela A. Amoako
- Dalles AndreDADalles Andre
Open Access
- 26 October 2022
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 13 (5) , e0178422
Abstract
SARS-CoV-2 is the cause of one of the largest noninfluenza pandemics of this century. This exceptional public health crisis highlights the urgent need for better understanding of the correlates of protection from infection and severe COVID-19.Keywords
All Related Versions
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (75N93019C00051, 75N93021C00014)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (75N93021C00014, 75N93019C00051)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (75N93019C00051)
This publication has 41 references indexed in Scilit:
- Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysisThe Lancet Infectious Diseases, 2021
- Robust neutralizing antibodies to SARS-CoV-2 infection persist for monthsScience, 2020
- Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York CityNature, 2020
- Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational studyThe Lancet Microbe, 2020
- Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack RateJournal of Clinical Microbiology, 2020
- Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern FranceEBioMedicine, 2020
- Introductions and early spread of SARS-CoV-2 in the New York City areaScience, 2020
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infectionsNature Medicine, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virusNature, 2008